UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000017669
Receipt No. R000020483
Scientific Title Safety of canagliflozin in diabetic patients with chronic heart failure: randomized, non-inferiority trial
Date of disclosure of the study information 2015/05/25
Last modified on 2020/07/29 16:41:05

No. Disposal Last modified on Item of update
1 Insert 2015/05/25 16:28:36
2 Update 2015/06/08 15:40:50 Institutions
3 Update 2015/08/13 16:21:15 Institutions
4 Update 2015/10/02 17:46:58 Key secondary outcomes
Key secondary outcomes
5 Update 2015/10/02 17:48:37 Institutions
6 Update 2015/11/18 09:26:50 Institutions
7 Update 2015/11/18 09:27:32 Recruitment status
8 Update 2016/05/16 16:47:21 Name of primary sponsor
Organization
Email1
9 Update 2016/06/06 17:35:21 Institutions
10 Update 2016/06/06 17:36:19 Randomization unit
11 Update 2016/07/19 15:00:09 Institutions
12 Update 2017/07/27 10:47:24 Recruitment status
13 Update 2017/07/27 10:49:47 Organization
Organization
Division name
Division name
14 Update 2018/05/18 15:42:15 Institutions
15 Update 2019/03/13 10:18:06 UMIN ID1
16 Update 2019/03/13 12:03:07 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Zip code
Email

Last name of contact person

Last name of contact person
Division name
Zip code
Email
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Email1
Organization
Organization
Address
Address
Tel
Email
17 Update 2019/05/28 13:40:40 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
18 Update 2020/07/29 16:35:01 Recruitment status
19 Update 2020/07/29 16:41:05 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.